Brain injury often causes balance and gait impairments. Neuromodulation offers a noninvasive, time-limited way to restore or significantly improve balance.

The FDA granted de novo approval for a neuromodulation device to treat symptoms associated with post-traumatic stress ...

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will participate in the 2026 American ...

Electrical transcutaneous neuromodulation (eTNM) of the peroneal nerve led to fewer side effects compared with solifenacin (Vesicare) in the treatment of overactive bladder, a randomized trial showed.

Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today highlighted the continued ...

The Food and Drug Administration granted de novo approval to Modius Spero, marking it the world’s first neuromodulation device authorized to ...

It is important to note that many of these technologies are still in early stages of development or clinical testing – they are not yet standard treatments, and what works for one person may not work ...

Researchers have developed a soft contact lens embedded with electrical stimulation electrodes that, in a mouse model of ...

At the 20th Annual Spine, Orthopedic + Pain Management-Driven ASC Conference, participants gathered to explore the latest advances in neuromodulation in ASCs and HOPDs. This session brought together a ...

Selective serotonin reuptake inhibitors (SSRIs) are considered the first-line, gold standard treatment for depression. However, their use is not without limitations, with commonly reported side ...

(NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular ...

Urinary retention without an identifiable urological cause presents a diagnostic and therapeutic challenge. Patients with nonobstructive chronic urinary retention usually have to rely on intermittent ...